Chemical Structure : SU14813
CAS No.: 627908-92-3
货号: PC-42622Not For Human Use, Lab Use Only.
SU14813 is a potent, broad-spectrum RTKs inhibitor with IC50 ranging from 2 to 50 nM for VEGFR-1, VEGFR-2, PDGFRs, KIT, FLT3, and CSF1R/FMS.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥780 | In stock | |
10 mg | ¥1180 | In stock | |
25 mg | ¥1980 | In stock | |
50 mg | ¥3280 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SU14813 is a potent, broad-spectrum RTKs inhibitor with IC50 ranging from 2 to 50 nM for VEGFR-1, VEGFR-2, PDGFRs, KIT, FLT3, and CSF1R/FMS.
SU14813 shows poor activity for EGFR and c-Met in biochemical assays.
SU14813 inhibits VEGFR-2, PDGFR-β, and KIT phosphorylation in porcine aorta endothelial cells with IC50 of 5.2, 9.9, and 11.2 nM respectively.
SU14813 is active in xenograft tumor models.
分子量 | 442.4833 | |
分子式 | C23H27FN4O4 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1H-Pyrrole-3-carboxamide, 5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-(4-morpholinyl)propyl]-2,4-dimethyl- |
1. Patyna S, et al. Mol Cancer Ther. 2006 Jul;5(7):1774-82.
2. Hu-Lowe D, et al. Mol Cancer Ther. 2011 Nov;10(11):2015.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright